Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis - meta-analysis

Osteoarthritis and Cartilage

Volumn 19, Issue 6, 2011, Pages 611-619

  Bannuru, R R ^a   Natov, N S ^b   Dasi, U R ^c   Schmid, C H ^a   McAlindon, T E ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ACHARYA NAGARJUNA UNIVERSITY   (India)

Author keywords

Hyaluronic acid; Intra articular; Knee; Meta analysis; Osteoarthritis

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO;

BAYES THEOREM; DRUG EFFICACY; HUMAN; JOINT FUNCTION; KNEE OSTEOARTHRITIS; META ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MODELS, THEORETICAL; OSTEOARTHRITIS, KNEE; PAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79955954713     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.09.014     Document Type: Review

References (75)

1. Peyron J.G. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol Suppl 1993, 39:10-15.
2. Balazs E.A., Denlinger J.L. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993, 39:3-9.
3. Moreland L.W. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003, 5:54-67.
4. Datamonitor Market Dynamics - Hyaluronic Acid Viscosupplementation 2002, Reference code DMHC1776. http://www.datamonitor.com.
5. Wobig M., Dickhut A., Maier R., Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998, 20:410-423.
6. Huskisson E.C., Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford) 1999, 38:602-607.
7. Altman R.D., Rosen J.E., Bloch D.A., Hatoum H.T., Korner P. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum 2009, 39:1-9.
8. Chevalier X., Jerosch J., Goupille P., van Dijk N., Luyten F.P., Scott D.L., et al. Single, intra-articular treatment with 6 mL of hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multi-centre, double-blind, placebo-controlled trial. Ann Rheum Dis 2008, 69(1):113-119.
9. Wang C.T., Lin J., Chang C.J., Lin Y.T., Hou S.M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004, 86-A:538-545.
10. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006, CD005321.
11. Lo G.H., LaValley M., McAlindon T., Felson D.T. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. Jama 2003, 290:3115-3121.
12. Modawal A., Ferrer M., Choi H.K., Castle J.A. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005, 54:758-767.
13. Arrich J., Piribauer F., Mad P., Schmid D., Klaushofer K., Mullner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005, 172:1039-1043.
14. Medina J.M., Thomas A., Denegar C.R. Knee osteoarthritis: should your patient opt for hyaluronic acid injection?. J Fam Pract 2006, 55:669-675.
15. Bannuru R.R., Natov N.S., Obadan I.E., Price L.L., Schmid C.H., McAlindon T.E. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 2009, 61:1704-1711.
16. Petrella R.J., Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol 2006, 33:951-956.
17. Lundsgaard C., Dufour N., Fallentin E., Winkel P., Gluud C. Intra-articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial. Scand J Rheumatol 2008, 37:142-150.
18. Petrella R.J., Cogliano A., Decaria J. Combining two hyaluronic acids in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Clin Rheumatol 2008, 27:975-981.
19. Baltzer A.W., Moser C., Jansen S.A., Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage 2009, 17:152-160.
20. Baraf H.S., Strand V., Hosokawa H., Akahane O., Lim S., Yaguchi M. Effectiveness and safety of a single intraarticular injection of GEL-200, a new cross-linked formulation of hyaluronic acid (HA) in the treatment of symptomatic osteoarthritis (OA) of the knee. Osteoarthritis Cartilage 2009, (17 Suppl). S174.
21. Cooper H., Hedges L.V. The Hand Book of Research Synthesis 1994, Russell Sage Foundation Publications, New York.
22. Karlsson J., Sjogren L.S., Lohmander L.S. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford) 2002, 41:1240-1248.
23. Rolf C.G., Engstrom B., Ohrvik J., Valentin A., Lilja B., Levine D.W. A comparative study of the efficacy and safety of hyaluronan viscosupplements and placebo in patients with symptomatic and arthroscopy-verified cartilage pathology. J Drug Assess 2005, 8:183-200.
24. Kotevoglu N., Iyibozkurt P.C., Hiz O., Toktas H., Kuran B. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int 2006, 26:325-330.
25. Schmid C.H., Stark P.C., Berlin J.A., Landais P., Lau J. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol 2004, 57:683-697.
26. Gelman A., Carlin J.B., Stern H.S., Rubin D.B. Bayesian Data Analysis 1996, Chapman and Hall, New York.
27. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
28. Ishak K.J., Platt R.W., Joseph L., Hanley J.A., Caro J.J. Meta-analysis of longitudinal studies. Clin Trials 2007, 4:525-539.
29. Dahlberg L., Lohmander L.S., Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum 1994, 37:521-528.
30. Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13.
31. Furukawa T.A., Barbui C., Cipriani A., Brambilla P., Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 2006, 59:7-10.
32. Thompson S.G., Sharp S.J. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999, 18:2693-2708.
33. Shichikawa K., Igarashi M., Sugawara S., Iwasaki Y. Clinical evaluation of high molecular weight sodium hyaluronate (SPH) on osteoarthritis of the knee - a mutli-center well controlled comparative study. Jpn J Clin Pharmacol Therapeut 1983, 14:545-558.
34. Shichikawa K., Maeda A., Ogawa N. [Clinical evaluation of sodium hyaluronate in the treatment of osteoarthritis of the knee]. Ryumachi 1983, 23:280-290.
35. Bragantini A., Cassini M., De Bastiani G. Controlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgan) in osteoarthritis of the knee. Clin Trials J 1987, 24:333-340.
36. Grecomoro G., Martorana U., Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 1987, 5:137-141.
37. Dixon A.S., Jacoby R.K., Berry H., Hamilton E.B. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 1988, 11:205-213.
38. Russell I.J., Michalek J.E., Lawrence V.A., Lessard J.A., Briggs B.T., May G.S. A randomized placebo (PL) and no-intervention (NI) controlled, trial of intra-articular (IA) 1% sodium hyaluronate (HA) in the treatment of knee osteoarthritis (OA). Arthritis Rheum 1992, (35 Suppl). S132.
39. Dougados M., Nguyen M., Listrat V., Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993, 1:97-103.
40. Moreland L.W., Arnold W.J., Saway A., Savory C., Sikes D. Efficacy and safety of intra-articular hylan G-F 20 (Synvisc), a viscoelastic derivative of hyaluronan, in patients with osteoarthritis of the knee. Arthritis Rheum 1993, (36 Suppl). S165.
41. Puhl W., Bernau A., Greiling H., Kopcke W., Pforringer W., Steck K.J., et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage 1993, 1:233-241.
42. Cohen M.A., Shiroky J.B., Ballachey M.L., Neville C., Esdaile J.M. Double-blind randomized trial of intra-articular (I/A) hyaluronate in the treatment of osteoarthritis of the knee. Arthritis Rheum 1994, (37 Suppl). R31.
43. Creamer P., Sharif M., George E., Meadows K., Cushnaghan J., Shinmei M., et al. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage 1994, 2:133-140.
44. Henderson E.B., Smith E.C., Pegley F., Blake D.R. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 1994, 53:529-534.
45. Scale D., Wobig M., Wolpert W. Viscosupplementation of osteoarthritis knees with hylan: a treatment schedule study. Curr Ther Res 1994, 55:220-232.
46. Carrabba M., Paresce E., Angelini M., Re K.A., Torchiana E.E.M., Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 1995, 15:25-31.
47. Corrado E.M., Peluso G.F., Gigliotti S., de Durante C., Palmieri D., Savoia M., et al. The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm 1995, 15:47-56.
48. FDA Document: Summary of Safety and Effectiveness Data: Sodium Hyaluronate January 24, 2001, Supartz® Rockville, MD. http://www.fda.gov/cdrh/pdf/P980044b.pdf.
49. Sala S.F., Miguel R.E. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a short term study. Eur J Rheumatol Inflamm 1995, 15:33-38.
50. Guler M., Kuran B., Parlar D., Guler M., Saglam H., Yapici S., et al. Clinical trial of intra-articular injection of hyaluronic acid in patients with osteoarthritis of the knee October 29-November 3, 1996, X National Rheumatology Congress, Turkey.
51. Lohmander L.S., Dalen N., Englund G., Hamalainen M., Jensen E.M., Karlsson K., et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 1996, 55:424-431.
52. Wu J.J., Shih L.Y., Hsu H.C., Chen T.H. The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei) 1997, 59:99-106.
53. Altman R.D., Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 1998, 25:2203-2212.
54. Hizmetli S, Kocagil S, Kaptanoglu E, Elden H, Nacitarhan V. The efficacy and safety of intra-articular hyaluronic acid in osteoarthritis of the knee: a prospective, double-blind trial. 1999, unpublished.
55. Brandt K.D., Block J.A., Michalski J.P., Moreland L.W., Caldwell J.R., Lavin P.T. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res 2001, 385:130-143.
56. Bunyaratavej N., Chan K.M., Subramanian N. Treatment of painful osteoarthritis of the knee with hyaluronic acid. Results of a multicenter Asian study. J Med Assoc Thai 2001, 2(84 Suppl):S576-S581.
57. Dickson D.J., Hosie G., English J.R. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Drug Assess 2001, 4:161-226.
58. Tamir E., Robinson D., Koren R., Agar G., Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol 2001, 19:265-270.
59. Petrella R.J., DiSilvestro M.D., Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2002, 162:292-298.
60. Jubb R.W., Piva S., Beinat L., Dacre J., Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 2003, 57:467-474.
61. Tsai C.-L., Chang C.-C., Chen S.-C., Beinat L., Piva S. Treatment of knee osteoarthritis in Asian population with an intra-articular hyaluronan of MW 500-730 KDa. Osteoarthritis Cartilage 2003, (11 Suppl). 119.
62. Altman R.D., Akermark C., Beaulieu A.D., Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2004, 12:642-649.
63. Day R., Brooks P., Conaghan P.G., Petersen M. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol 2004, 31:775-782.
64. Pham T., Le Henanff A., Ravaud P., Dieppe P., Paolozzi L., Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis 2004, 63:1611-1617.
65. Cubukcu D., Ardic F., Karabulut N., Topuz O., Hylan G- F. 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol 2005, 24:336-341.
66. Neustadt D., Caldwell J., Bell M., Wade J., Gimbel J. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol 2005, 32:1928-1936.
67. Sezgin M., Demirel A.C., Karaca C., Ortancil O., Ulkar G.B., Kanik A., et al. Does hyaluronan affect inflammatory cytokines in knee osteoarthritis?. Rheumatol Int 2005, 25:264-269.
68. Towheed T.E., Maxwell L., Judd M.G., Catton M., Hochberg M.C., Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006, CD004257.
69. Zhang W., Nuki G., Moskowitz R.W., Abramson S., Altman R.D., Arden N.K., et al. OARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010, 18(4):476-499.
70. Lee C., Hunsche E., Balshaw R., Kong S.X., Schnitzer T.J. Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis. Arthritis Rheum 2005, 53:510-518.
71. Dworkin R.H., Turk D.C., Wyrwich K.W., Beaton D., Cleeland C.S., Farrar J.T., et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008, 9:105-121.
72. Zhang W., Robertson J., Jones A.C., Dieppe P.A., Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008, 67:1716-1723.
73. Kirwan J.R., Rankin E. Intra-articular therapy in osteoarthritis. Baillieres Clin Rheumatol 1997, 11:769-794.
74. Brandt K.D., Smith G.N., Simon L.S. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?. Arthritis Rheum 2000, 43:1192-1203.
75. Towheed T.E., Hochberg M.C. A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. Semin Arthritis Rheum 1997, 26:755-770.